Andrew Udell
Net worth: 275 742 $ as of 2024-03-30
Profile
Andrew B.
Udell worked as the President-North America Region at Calliditas Therapeutics AB from 2021 to 2024 and as the Vice President-North America Commercial at NeuroDerm Ltd.
from 2017 to 2018.
He completed his undergraduate degree at Lehigh University and earned an MBA from the University of Connecticut.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-02-27 | 26,000 ( 0.04% ) | 275 742 $ | 2024-03-30 |
Former positions of Andrew Udell
| Companies | Position | End |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 2024-01-06 |
| NEURODERM LTD | Corporate Officer/Principal | 2018-05-31 |
Training of Andrew Udell
| Lehigh University | Undergraduate Degree |
| University of Connecticut | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| Private companies | 1 |
|---|---|
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
- Stock Market
- Insiders
- Andrew Udell
